ProCE Banner Series

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

Register now for this CME/CNE/CPE/AAPA-certified interactive workshop series for community hematologists/oncologists and other multidisciplinary team members on up-to-date treatment strategies for patients with polycythemia vera (PV)! After the meeting, download the associated slideset and read an expert commentary answering questions from the community.

  AAPA
  | ACPE
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This program is intended for community-based medical hematologists/oncologists, advanced practice providers, nurses, pharmacists and other healthcare professionals involved in the treatment of patients with polycythemia vera.

All Events

Past Events

August

03

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

7:00 PM - 8:00 PM Eastern Time (ET)

Virtual

Private Event, Oakland Gardens, New York

August

12

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

8:00 AM - 9:00 AM Central Time (CT)

In-personVirtual

Private Event | Host Group at Table 100, Flowood, Mississippi

August

22

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

3:30 PM - 4:30 PM Mountain Time (MT)

Virtual

Private Event | Host Group NM, Rio Rancho, New Mexico

August

29

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Private Event | Host Group MI, Royal Oak, Michigan

September

07

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

11:00 AM - 12:00 PM Central Time (CT)

Virtual

Private Event | Host Group AL, Mobile, Alabama

September

28

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

6:30 PM - 7:30 PM Eastern Time (ET)

In-person

Private Event | Host Group at Mark's Prime, Gainesville, Florida

October

04

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

3:00 PM - 4:00 PM Eastern Time (ET)

Virtual

Private Event | Virtual, Lexington, Kentucky

October

10

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

7:00 PM - 8:00 PM Eastern Time (ET)

In-person

Private Event | Host Group Franklin, Franklin Square, New York

October

11

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

6:00 PM - 7:00 PM Eastern Time (ET)

In-person

Private Event | Host Group at La Cipollina, Freehold, New Jersey

October

13

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

11:30 AM - 12:30 PM Central Time (CT)

Virtual

Private Event | Virtual Group, Omaha, Nebraska

November

14

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

7:30 AM - 8:30 AM Pacific Time (PT)

Virtual

Private Event | Virtual Group ID, Post Falls, Idaho

December

04

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice [Open Registration]

11:30 AM - 12:30 PM Central Time (CT)

Virtual

CCO Simulcast | Host Group TX, Dallas, Texas

December

07

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

11:30 AM - 12:30 PM Eastern Time (ET)

In-person

Private Event | Host Group WDC, Washington, District of Columbia

December

11

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

7:00 PM - 8:00 PM Pacific Time (PT)

In-person

Private Event | Host Group CA, Fremont, California

December

15

2023

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

8:30 AM - 9:30 AM Mountain Time (MT)

Virtual

Virtual Event | Host Group in NM, Albuquerque, New Mexico

January

10

2024

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

4:30 PM - 5:30 PM Central Time (CT)

Virtual

Virtual Event | Host Group in OK, Norman, Oklahoma

January

12

2024

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice [Open Registration]

7:00 AM - 8:00 AM Eastern Time (ET)

Virtual

CCO Simulcast | Host Group NC, Hendersonville, North Carolina

January

16

2024

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

12:30 PM - 1:30 PM Eastern Time (ET)

Virtual

Virtual Event | Host Group in SC, Columbia, South Carolina

January

25

2024

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

9:00 AM - 10:00 AM Mountain Time (MT)

Virtual

Virtual Event | Host Group in WY, Sheridan, Wyoming

January

26

2024

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

8:30 AM - 9:30 AM Eastern Time (ET)

Virtual

Virtual Event | Host Group in VT, Bennington, Vermont

January

30

2024

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice [Open Registration]

11:30 AM - 12:30 PM Central Time (CT)

Virtual

CCO Simulcast | Host Group TX, Decatur, Texas

February

28

2024

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

3:00 PM - 4:00 PM Mountain Time (MT)

Virtual

Virtual Event | Host Group in CO, Grand Junction, Colorado

Faculty

ProCE Banner Faculty
Ghaith Abu-Zeinah, MD

Assistant Professor of Medicine
Department of Hematology and Medical Oncology
Weill Cornell Medicine
New York, New York

ProCE Banner Faculty
Prithviraj Bose, MD

Professor
Department of Leukemia
UT MD Anderson Cancer Center
Houston, Texas

ProCE Banner Faculty
Aaron T. Gerds, MD, MS

Assistant Professor of Medicine 
Hematology and Medical Oncology 
Cleaveland Clinic Taussig Cancer Institute
Cleaveland, Ohio 

ProCE Banner Faculty
Andrew Kuykendall, MD

Assistant Professor
Department of Oncologic Sciences
University of South Florida
Assistant Member, Malignant Hematology
H. Lee Moffitt Cancer Center
Tampa, Florida

ProCE Banner Faculty
John Mascarenhas, MD

Director, Adult Leukemia Program
Leader, Myeloproliferative Disorders Clinical Research Program
Division of Hematology/Oncology
Tisch Cancer Institute 
Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

ProCE Banner Faculty
Kristen M. Pettit, MD

Clinical Associate Professor
Rogel Cancer Center
University of Michigan
Ann Arbor, Michigan

ProCE Banner Faculty
Raajit K. Rampal, MD, PhD

Associate Member
Director, MPN and Rare Hematologic Malignancies Program
Director, Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York

ProCE Banner Faculty
Tsewang Tashi, MD

Associate Professor 
Division of Hematology and Hematologic Malignancies 
Huntsman Cancer Institution, University of Utah
Salt Lake City, Utah 

ProCE Banner Faculty
Douglas Tremblay, MD

Assistant Professor of Medicine
Department of Hematology and Oncology
Tisch Cancer Institute
Ichan School of Medicine 
New York, New York

ProCE Banner Faculty
Pankit Vachhani, MD

Associate Professor of Medicine, UAB Division of Hematology/Oncology
Medical Director, Clinical Research Unit (CRU) at UAB
O’Neal Comprehensive Cancer Center at UAB
Birmingham, Alabama

Topics

  • State-of-the-art diagnosis, classification, and molecular prognostication of PV
  • Fine-tuning PV treatment: upfront and refractory to initial cytoreductive therapy
  • Consensus guideline‒preferred regimens for PV refractory to initial therapy
  • Special considerations in the treatment of PV
  • Investigational strategies on the horizon

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Goal
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Myeloproliferative neoplasms (MPN)

Target Audience
This program is intended for community-based medical hematologists/oncologists, advanced practice providers, nurses, pharmacists and other healthcare professionals involved in the treatment of patients with polycythemia vera. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify factors used to stratify risk and initiate cytoreductive therapy in PV, including potentially disease-modifying therapies in low-risk PV
  • Recognize symptoms and patterns of first-line treatment failure in patients with MPNs, including treatment intolerance and treatment resistance
  • Institute best practices for transitioning to a clinically appropriate second-line therapy after first-line treatment failure for patients with PV
  • Integrate supportive care plans into practice that are designed to monitor symptoms and manage treatment-related toxicities from current and emerging PV treatments
  • Review data on emerging novel targets and mechanisms that have the potential to change clinical practice in PV and ET

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-23-142-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate/Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by educational grants from PharmaEssentia USA Corporation and Incyte Corporation.